Avidity Biosciences (RNA)
(Delayed Data from NSDQ)
$43.50 USD
-0.98 (-2.20%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $43.51 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.80 | 0.00% |
Earnings Summary
For their last quarter, Avidity Biosciences (RNA) reported earnings of -$0.65 per share, beating the Zacks Consensus Estimate of $-0.76 per share. This reflects a positive earnings surprise of 14.47%. Look out for RNA's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.80 per share, reflecting a year-over-year decrease of 12.68%.
Earnings History
Price & Consensus
Zacks News for RNA
Avidity Biosciences, Inc. (RNA) Reports Q2 Loss, Misses Revenue Estimates
RNA: What are Zacks experts saying now?
Zacks Private Portfolio Services